Home › Research › Risk factors
Alzheimer’s Disease and related dementias prevalence higher in Appalachian counties within Central Appalachia
Jeffrey J. Wing, Jenna I. Rajczyk, James Francis Burke. Alzheimer s & Dementia, 2024-12-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Abstract Background Alzheimer’s disease and related dementias (ADRD) prevalence varies geographically in the US. The Appalachian region has lower educational attainment and health care access barriers compared to non‐Appalachian regions. The objective of this proposal is to assess whether the geographic variation of ADRD in Central Appalachia is explained by county‐level sociodemographic factors or access to care. Methods Centers for Medicare and Medicaid Services Public Use Files from 2015‐2018 were used to estimate county‐level ADRD prevalence among all fee‐for‐service beneficiaries in Central Appalachia (Kentucky, North Carolina, Ohio, Tennessee, Virginia, and West Virginia). Negative binomial regression was used to estimate prevalence overall, by Appalachian Regional Commission’s Appalachian/non‐Appalachian designation, and by rural/urban (Rural‐Urban Continuum Codes) classification. Models were then adjusted for: (1) county‐level demographics including age, gender, Medicaid eligibility, and comorbidities (atrial fibrillation, chronic kidney disease, depression, diabetes, heart failure, hyperlipidemia, hypertension, ischemic heart disease, schizophrenia/other psychotic disorders, and stroke); (2) sociodemographics (race/ethnic distribution, education, aging population distribution, and renter‐occupied housing); and (3) diagnostic access (PCP visits, neurology visits, and imaging scans). Results A total of 592 counties comprise the Central Appalachian region where 43% (n = 255) are Appalachian and 45% (n = 267) are rural counties. The prevalence of ADRD did not vary over the time period but was higher for Appalachian counties both overall (PR: 1.03; 95% CI: 1.02, 1.04) and after adjustment (PR: 1.02; 95% CI: 1.00, 1.03) compared to non‐Appalachian counties. This difference was similar among rural and urban counties (p = 0.326). These differences did vary across the states in the region (p = 0.0040). In North Carolina and Tennessee, Appalachian counties had higher ADRD prevalence, while in Ohio and Tennessee, rural counties have lower ADRD prevalence. Conclusion There is a consistent difference between Appalachian and non‐Appalachian counties, with Appalachian counties having relatively higher ADRD prevalence (in the range of 2.0‐3.0% times higher) than non‐Appalachian counties. These differences persisted even after considering age, education, other sociodemographic factors and access to care measures.
What this study adds
Evidence grade: Low
The record lists 255 participants. This study examined county-level prevalence of Alzheimer's disease and related dementias in Central Appalachia and whether geographic variation was explained by sociodemographic factors or access to care. Reported effect size: 3.0%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Wing, J. J., Rajczyk, J. I., & Burke, J. F. (2024). Alzheimer’s Disease and related dementias prevalence higher in Appalachian counties within Central Appalachia. Alzheimer s & Dementia. https://doi.org/10.1002/alz.087720
Vancouver
Wing JJ, Rajczyk JI, Burke JF. Alzheimer’s Disease and related dementias prevalence higher in Appalachian counties within Central Appalachia. Alzheimer s & Dementia. 2024. doi:10.1002/alz.087720.
BibTeX
@article{wing2024-3af500af,
author = {Wing, Jeffrey J. and Rajczyk, Jenna I. and Burke, James Francis},
title = {{Alzheimer’s Disease and related dementias prevalence higher in Appalachian counties within Central Appalachia}},
journal = {Alzheimer s \& Dementia},
year = {2024},
doi = {10.1002/alz.087720},
url = {https://doi.org/10.1002/alz.087720}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- The Appalachian region has lower educational attainment and health care access barriers compared to non‐Appalachian regions.
- Negative binomial regression was used to estimate prevalence overall, by Appalachian Regional Commission’s Appalachian/non‐Appalachian designation, and by rural/urban (Rural‐Urban Continuum Codes) classification.
- Results A total of 592 counties comprise the Central Appalachian region where 43% (n = 255) are Appalachian and 45% (n = 267) are rural counties.
- The prevalence of ADRD did not vary over the time period but was higher for Appalachian counties both overall (PR: 1.03; 95% CI: 1.02, 1.04) and after adjustment (PR: 1.02; 95% CI: 1.00, 1.03) compared to non‐Appalachian counties.
Why it matters
This study examined county-level prevalence of Alzheimer's disease and related dementias in Central Appalachia and whether geographic variation was explained by sociodemographic factors or access to care. The abstract does not report the final results of these analyses.
New to this subject? Start with our plain-English guide: Risk factors, ranked →
Study details
- Participants255
- Effect size3.0%
- Evidence strengthLow
How this study scored 38/100
Published in a peer-reviewed journal. Scored zero for study design and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2024 — within 3 year(s) of the newest study here |
| Sample size | 2 / 4 | 255 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 4 year(s) since 2024 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author James Francis Burke: h-index 61 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | The Ohio State University: institution h-index 1,378 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 2 / 2 | Free to read |
| Total | 38 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Risk factors from nearby years
Also tagged “biobank”
1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.